IRIS UniCatt

Avolio, Alfonso Wolfango
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.973
EU - Europa 5.460
AS - Asia 5.247
SA - Sud America 1.033
AF - Africa 124
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 12
Totale 18.861
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.766
SG - Singapore 2.256
DE - Germania 1.573
CN - Cina 1.437
SE - Svezia 903
BR - Brasile 844
IT - Italia 685
UA - Ucraina 538
FR - Francia 474
VN - Vietnam 464
GB - Regno Unito 306
IE - Irlanda 273
FI - Finlandia 190
PL - Polonia 180
BD - Bangladesh 162
ID - Indonesia 161
IN - India 142
JP - Giappone 140
CA - Canada 112
TR - Turchia 95
HK - Hong Kong 89
RU - Federazione Russa 89
AR - Argentina 72
IQ - Iraq 58
MX - Messico 57
BE - Belgio 43
KR - Corea 41
ZA - Sudafrica 41
ES - Italia 35
IR - Iran 29
EC - Ecuador 27
VE - Venezuela 27
AT - Austria 26
NL - Olanda 25
PK - Pakistan 25
LT - Lituania 22
SA - Arabia Saudita 22
CH - Svizzera 20
UZ - Uzbekistan 20
CL - Cile 17
CO - Colombia 17
MA - Marocco 17
KE - Kenya 16
RO - Romania 15
AE - Emirati Arabi Uniti 14
PH - Filippine 12
TN - Tunisia 12
CZ - Repubblica Ceca 10
EG - Egitto 10
EU - Europa 10
PY - Paraguay 10
TH - Thailandia 10
UY - Uruguay 9
AU - Australia 8
JM - Giamaica 8
MY - Malesia 8
AZ - Azerbaigian 7
BY - Bielorussia 7
CI - Costa d'Avorio 7
DO - Repubblica Dominicana 7
JO - Giordania 7
KZ - Kazakistan 7
NP - Nepal 7
PE - Perù 7
BG - Bulgaria 6
DK - Danimarca 6
GR - Grecia 5
PA - Panama 5
EE - Estonia 4
HN - Honduras 4
MD - Moldavia 4
OM - Oman 4
PT - Portogallo 4
SY - Repubblica araba siriana 4
TW - Taiwan 4
AO - Angola 3
BH - Bahrain 3
DZ - Algeria 3
ET - Etiopia 3
GT - Guatemala 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
AL - Albania 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BW - Botswana 2
BZ - Belize 2
CW - ???statistics.table.value.countryCode.CW??? 2
GA - Gabon 2
GD - Grenada 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
KG - Kirghizistan 2
KH - Cambogia 2
LB - Libano 2
MU - Mauritius 2
NO - Norvegia 2
Totale 18.836
Salva come PNG Salva come JPEG
Città #
Singapore 1.088
Ashburn 794
Chandler 772
San Jose 589
Jacksonville 291
Beijing 281
Dublin 264
San Mateo 235
Los Angeles 187
New York 181
Ann Arbor 177
Munich 165
Rome 158
Nanjing 155
Ho Chi Minh City 153
Jakarta 142
Lauterbourg 140
Wilmington 130
Hanoi 124
Tokyo 124
Boston 119
The Dalles 119
Warsaw 114
Milan 105
Hefei 102
Marseille 98
Woodbridge 90
Seattle 87
Frankfurt am Main 83
Mcallen 83
Lawrence 82
Buffalo 79
Houston 78
Dearborn 77
Chicago 76
Hong Kong 74
Dallas 73
Santa Clara 73
Nürnberg 72
Bremen 68
Redwood City 68
Fairfield 64
Nanchang 62
Izmir 60
Helsinki 58
São Paulo 56
Moscow 54
Shenyang 54
Cattolica 49
Hangzhou 47
Princeton 47
Hebei 42
University Park 41
Zhengzhou 41
Brussels 39
Tianjin 37
Lancaster 36
Andover 33
St Louis 33
London 31
Kraków 30
Shanghai 29
Toronto 29
Augusta 28
Johannesburg 28
Mountain View 28
Atlanta 27
Changsha 27
Guangzhou 27
Kunming 27
Nuremberg 27
Turku 26
Baghdad 25
Rio de Janeiro 25
Council Bluffs 24
Montréal 24
Seoul 24
Dhaka 23
Pune 23
Belo Horizonte 22
Da Nang 22
Kent 22
Norwalk 22
Brooklyn 21
Boardman 20
Chengdu 20
Jiaxing 19
Paris 19
Phoenix 19
Charlotte 18
Curitiba 18
Detroit 18
Haiphong 18
Ningbo 18
Tukwila 18
Fremont 17
Hounslow 17
Kish 17
Mexico City 17
San Francisco 17
Totale 9.754
Salva come PNG Salva come JPEG
Nome #
Low values of left ventricular ejection time in the post-anhepatic phase may be associated with occurrence of primary graft dysfunction after orthotopic liver transplantation: results of a single-centre case-control study 413
Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer 367
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 354
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs. 326
Development and Validation of a Comprehensive Model to Estimate Early Allograft Failure Among Patients Requiring Early Liver Retransplant 239
Molecular adsorbent recirculating system in liver transplantation: Safety and efficacy.- 224
Postoperative respiratory failure in liver transplantation: Risk factors and effect on prognosis 209
Duplex Doppler in the postoperative monitoring of liver transplant recipients 207
Prediction of poor graft function by means of gastric tonometry in patients undergoing liver transplantation 203
Accidental transplantation of a kidney with stones: case report 195
Liver transplantation in patients with alcoholic liver disease: A retrospective study 191
Optimization of Donor-Recipient match and identification of the futile match cutoff. A national italian study on liver transplantation. 190
Importance of donor blood chemistry data (AST, serum sodium) in predicting liver transplant outcome 186
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 186
Use of an esophageal echo-Doppler device during liver transplantation: preliminary report 184
Thromboelastography does not reduce transfusion requirements in liver transplantation: A propensity score-matched study 182
Intensive Care Unit-Acquired Weakness after Liver Transplantation: Analysis of Seven Cases and a Literature Review 173
Incidence of upper aerodigestive tract cancer after liver transplantation for alcoholic cirrhosis: a 10-year experience in an Italian center 170
Acute Liver Failure in an Adult, a Rare Complication of Alagille Syndrome: Case Report and Brief Review 167
Enteric-coated mycophenolate sodium: one-way conversion from mycophenolate mofetil and de novo use in stable liver transplant recipients 164
Enzymatic determinations in acute rejection after liver transplantation: preliminary report on necrosis index 163
http://www.D-MELD.com, the Italian survival calculator to optimize donor to recipient matching and to identify the unsustainable matches in liver transplantation 163
A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy 161
Lack of predictivity of serum neopterin, soluble interleukin-2 receptor, and serum amyloid A in long-term kidney transplant recipients 161
Incidence, management, and results of hepatic artery stenosis after liver transplantation in the era of donor to recipient match 161
Discrepancy Between Conventional Coagulation Tests and Thromboelastography During the Early Postoperative Phase of Liver Resection in Neoplastic Patients: A Prospective Study Using the New-Generation TEG®6s 160
Comparative evaluation of two perfusion solutions for liver preservation and transplantation. 159
Graft steatosis as a risk factor of ischemic-type biliary lesions in liver transplantation 157
Pediatric T-tube in adult liver transplantation: Technical refinements of insertion and removal 157
Factors predicting ischemic-type biliary lesions (ITBLs) after liver transplantation 155
Liver transplantation for hepatitis B virus patients: long-term results of three therapeutic approaches 154
Prediction of 6-month survival after liver transplantation using Cox regression. 152
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs 150
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 150
Mitochondrial liver enzymes and the ratio between mitochondrial and cytoplasmic enzymes in the differential diagnosis of acute rejection after liver transplantation 149
Orthotopic liver transplantation after successful treatment with anti-CD20 monoclonal antibody (rituximab) for severe steroid-resistant autoimmune hemolytic anemia: a case report 149
A Bayesan methodology to improve prediction of early graft loss after liver transplantation derived from the liver match study. 149
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 149
Viscoelastic versus conventional coagulation tests to reduce blood product transfusion in patients undergoing liver transplantation: A systematic review and meta-analysis 148
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients 148
Orpitt: a computerized chart for intraoperative real time management of liver transplant data 147
D-MELD, a strong and accurate tool to guide donor-2-recipient matching 147
Proposal and validation of a liver graft discard score for liver transplantation from deceased donors: a multicenter Italian study 147
[Blood recovery and autotransfusion within integrated transfusion systems during liver transplantation. The authors' own experience] 145
Is primary nonfunction still a suitable indication for liver retransplantation? 145
Development and validation of a comprehensive model to predict complications after hepatectomy 145
-Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 144
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient. 144
L-GrAFT and EASE scores in liver transplantation. Need for a reciprocal external validation and comparison with other scores 144
Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 143
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV patients. 143
High intraoperative blood product requirements in liver transplantation: Risk factors and impact on the outcome 141
Model for end-stage liver disease dynamic stratification of survival benefit 137
-Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 136
Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact 136
Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation 135
Psychological risk factors for graft rejection among liver transplant recipients 134
Availability of a Web and Smartphone Application to Stratify the Risk of of Early Allograft Failure Requiring Liver Retransplantation 132
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 132
Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation 131
Paradoxical effect of short-term protein loading on CsA-treated kidney transplant recipients 130
Postoperative respiratory failure in liver transplantation: Risk factors and effect on prognosis 130
Determinants of hemodynamic compensation during veno-venous bypass in liver transplantation 129
Increase in N-acetyl-beta-glucosaminidase excretion as a marker of kidney damage in cyclosporine-treated renal allografts 129
Results of liver transplantation for hepatitis delta disease without immunoprophylaxis 128
The mismatch choice in liver transplantation: a suggestion for the selection of the recipient in relation to the characteristics of the donor. 127
Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival 127
High-Flow Nasal Cannula Versus Standard Oxygen Therapy After Extubation in Liver Transplantation: A Matched Controlled Study 127
Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact 127
Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections 126
Reply to Riva et al. Comment on "Gaspari et al. Blood Purification in Hepatic Dysfunction after Liver Transplant or Extensive Hepatectomy: Far from the Best-Case Scenarios 125
Mitochondrial/cytoplasmic enzyme ratio for the diagnosis of acute rejection after liver transplantation: sensitivity and specificity 125
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 123
CONUT Score Predicts Early Morbidity After Liver Transplantation: A Collaborative Study 123
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 122
Blood Purification in Hepatic Dysfunction after Liver Transplant or Extensive Hepatectomy: Far from the Best-Case Scenarios 121
Donor Risk Index and Organ Patient Index as Predictors of Graft Survival After Liver Transplantation 121
Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 119
Letter to the Editor: Suboptimal performance of CAR-OLT score to predict 1-year risk of cardiovascular events after liver transplantation 119
Personalized Therapy in a Multidisciplinary Team Improves Survival in Patient with HCC: The Hepatocatt Experience 117
Primary difunction after liver trasplantation: donor or recipients fault? 117
Use of O blood group liver donors for nonidentical recipients: does this represent a double penalty for O blood group candidates? 117
Possibility of recognizing immunologic and cyclosporine A damage by urinary neopterin excretion in kidney transplant recipients 116
Intraoperative trends of oxygen consumption and blood lactate as predictors of primary dysfunction after liver transplantation 116
Coenzyme Q. alpha tocopherol graft uptake and lipid peroxidation in human liver transplantation: evidence of energy metabolism protection in University of Wisconsin (UW) solution-preserved livers 116
Celiac axis compression syndrome in liver transplantation 112
Proposal of a new evidence based definition of Early Allograft Failure to identify patients who needs early retransplant and call for a prospective external validation study 111
Preoperative recipient data and immunosuppression levels are predictive of early patient survival after liver transplantation 111
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 111
Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation 111
Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation. 109
Quantification of liver damage and prediction of 1-year survival after liver transplantation by a multifactorial "recovery score" 109
Should retransplantation still be considered for primary non-function after liver transplantation? 109
Clinical problems of the transplanted kidney 108
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 106
Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer 106
Can the Rank of Survival Benefit Be Used as a Priority Allocation System in an European Liver Transplant Waiting List? Evidences from an Italian Multicentre Cohort Study 106
Toward a novel evidence-based definition of early allograft failure in the perspective of liver retransplant. 105
Human humoral immune reactions against pig antigens: a method to clear preexisting preformed natural antibodies 104
Alpha-fetoprotein and modified response evaluation criteria in solid tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation 104
Totale 15.132
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.416
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.416
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.377 85 188 32 108 66 52 11 226 60 56 220 273
2022/20232.323 279 300 219 346 139 291 132 185 252 55 100 25
2023/20241.184 48 378 25 159 54 118 82 38 15 54 106 107
2024/20252.573 45 61 199 95 202 113 66 97 414 282 568 431
2025/20266.537 1.008 204 404 768 1.025 303 1.046 289 368 511 244 367
2026/2027272 272 0 0 0 0 0 0 0 0 0 0 0
Totale 19.048